In a significant move to enhance healthcare and life sciences, Anthropic announced the launch of new features for its AI model, Claude, in October 2023. The company introduced two major expansions: Claude for Healthcare, designed for medical applications, and enhanced capabilities for life sciences. These advancements aim to position Claude as a vital partner for clinicians, researchers, and industry professionals working to bring scientific innovations to the public.
The rollout of Claude for Healthcare includes a suite of tools tailored for healthcare providers, payers, and consumers. These tools are compliant with the Health Insurance Portability and Accountability Act (HIPAA), ensuring that sensitive patient data remains secure. The enhancements allow Claude to connect directly with various healthcare platforms, streamlining access to critical information.
Among the new connectors is access to the Centers for Medicare & Medicaid Services (CMS) Coverage Database. This feature enables Claude to verify coverage requirements and support prior authorization checks, potentially expediting the process for patients needing immediate care. Additionally, Claude can now interface with the International Classification of Diseases (ICD-10) to assist with medical coding and billing accuracy.
Another significant addition is the inclusion of the National Provider Identifier Registry, which aids in provider verification and credentialing. Claude’s integration with PubMed, which houses over 35 million biomedical literature pieces, allows users to easily access the latest research findings.
The launch also introduces new Agent Skills, such as FHIR development—important for improving data exchange between healthcare systems—and a customizable prior authorization review template. These capabilities are designed to streamline administrative tasks, reducing the burden on healthcare professionals.
With these tools, Claude can facilitate critical processes like speeding up prior authorization reviews and supporting claims appeals. By efficiently gathering and analyzing necessary information, Claude aims to alleviate delays that can hinder patient access to essential care.
In the life sciences sector, Claude is expanding its functionalities to support clinical trial operations and regulatory submissions. Enhancements include new connectors to Medidata, a leader in clinical trial solutions, and ClinicalTrials.gov, the U.S. clinical trials registry. These connections enable Claude to access historical trial data, enrollment information, and performance metrics, assisting researchers in managing clinical trials more effectively.
The integration with preprint servers like bioRxiv and medRxiv allows Claude to source the latest research developments before formal publication. This capability is crucial for scientists aiming to remain at the forefront of their fields.
Claude’s new skills also encompass drafting clinical trial protocols in compliance with FDA standards, which enhances the efficiency of regulatory submissions. This functionality is expected to significantly reduce the time required for organizations to prepare and submit necessary documentation to regulatory agencies.
The impact of these innovations has been echoed by several organizations in the healthcare and life sciences sectors. For example, Sanofi noted that their collaboration with Anthropic has transformed the way they automate tasks, allowing their teams to focus on high-value scientific work. Other partners highlighted the advantages of using Claude in accelerating patient care and improving operational efficiency.
As Claude continues to evolve, it is now available to a broader audience, including Claude Pro, Max, Teams, and Enterprise subscribers. Organizations interested in adopting these new capabilities can reach out to Anthropic’s sales team for further information.
The enhancements to Claude reflect Anthropic’s commitment to leveraging artificial intelligence responsibly and effectively in healthcare and life sciences, ultimately aiming to improve patient outcomes and streamline complex processes across the industry.
